Commercializing biomedical science in a rapidly changing “triple-helix” nexus: The experience of the National University of Singapore
Since the late 1990s, the Singapore government had embarked on a significant push to develop the city-state into a major life-science R&D and industrial cluster in Asia. Although a major focus of this new thrust involves attracting leading life science companies overseas to establish operations...
Gespeichert in:
| Veröffentlicht in: | The Journal of technology transfer 2007-08, Vol.32 (4), p.367-395 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 395 |
|---|---|
| container_issue | 4 |
| container_start_page | 367 |
| container_title | The Journal of technology transfer |
| container_volume | 32 |
| creator | Wong, Poh-Kam |
| description | Since the late 1990s, the Singapore government had embarked on a significant push to develop the city-state into a major life-science R&D and industrial cluster in Asia. Although a major focus of this new thrust involves attracting leading life science companies overseas to establish operations in Singapore and developing new public life science research institutions to attract overseas life science research talents (Finegold, Wong, and Cheah (2004)), the local universities are expected to play an important role as well. In particular, the National University of Singapore (NUS), the leading university in Singapore, has also started to pursue major strategic change to become more “entrepreneurial”, and identified life science as a major focus for technology commercialization as well. Adapting the “Triple-Helix” framework of Etzkowitz, Webster, Gebhardt, & Terra (2000), this paper examines the significant changes in the university-government-industry “Triple-Helix” nexus for life science in Singapore, and their consequent impact on life science commercialization at NUS. Implications for universities in other late-comer countries seeking to catch up in the global biotech race are discussed. |
| doi_str_mv | 10.1007/s10961-006-9020-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1082186070</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1279164641</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-e6a251ba9b7b70fa25bcae7fbc00144be2cb2cce5997912c1236ee1769187c6c3</originalsourceid><addsrcrecordid>eNpdkb1OwzAQxyMEEp8PwITFxBI4O00cs6GKLwnBUDpbjrm0Rkkc7BS1TF15B3i5PgmOwoCYfL773U86_aPomMI5BeAXnoLIaAyQxQIYxLAV7UEuWCwEZdt_6t1o3_tXABgB43vR59jWNTptVGU-TDMjhbE1vhitKuK1wUYjMQ1RxKnWvFQroueqmfXgZv3VOdNWGM-xMsvN-ps0uFz4S_I8R4LLFt2wbkvShc6j6oxtgnbamHd03nSrfjQJLtVah4fRTqkqj0e_70E0vbl-Ht_FD0-39-Orh1iPIOlizBRLaaFEwQsOZfgUWiEvCw1AR6MCmS6Y1pgKwcO5mrIkQ6Q8EzTnOtPJQXQ2eFtn3xboO1kbr7GqVIN24SWFnNE8Aw4BPf2HvtqFCzd4ySDJ0kTwNEB0gLSz3jssZetMrdwqmGSfjRyykSEb2Wcje_HJsFMqK9XMGS-nEwY0CTjPRcqSHxkUjug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>203653975</pqid></control><display><type>article</type><title>Commercializing biomedical science in a rapidly changing “triple-helix” nexus: The experience of the National University of Singapore</title><source>SpringerLink Journals - AutoHoldings</source><creator>Wong, Poh-Kam</creator><creatorcontrib>Wong, Poh-Kam</creatorcontrib><description>Since the late 1990s, the Singapore government had embarked on a significant push to develop the city-state into a major life-science R&D and industrial cluster in Asia. Although a major focus of this new thrust involves attracting leading life science companies overseas to establish operations in Singapore and developing new public life science research institutions to attract overseas life science research talents (Finegold, Wong, and Cheah (2004)), the local universities are expected to play an important role as well. In particular, the National University of Singapore (NUS), the leading university in Singapore, has also started to pursue major strategic change to become more “entrepreneurial”, and identified life science as a major focus for technology commercialization as well. Adapting the “Triple-Helix” framework of Etzkowitz, Webster, Gebhardt, & Terra (2000), this paper examines the significant changes in the university-government-industry “Triple-Helix” nexus for life science in Singapore, and their consequent impact on life science commercialization at NUS. Implications for universities in other late-comer countries seeking to catch up in the global biotech race are discussed.</description><identifier>ISSN: 0892-9912</identifier><identifier>EISSN: 0892-9912</identifier><identifier>EISSN: 1573-7047</identifier><identifier>DOI: 10.1007/s10961-006-9020-0</identifier><language>eng</language><publisher>Indianapolis: New York : Kluwer Academic Publishers-Plenum Publishers</publisher><subject>Biomedical research ; Biotechnology ; Biotechnology industry ; Clusters ; Colleges & universities ; Commercialization ; Competition ; Economic development ; Economic growth ; Effects ; Entrepreneurs ; Funding ; Globalization ; Governments ; Health care policy ; Innovations ; issues and policy ; Life sciences ; Manufacturing ; Overseas ; Pharmaceutical industry ; Public policy ; Race ; Regional differences ; research and development ; Research centers ; Studies ; Technology transfer ; Thrust ; University research ; Venture capital</subject><ispartof>The Journal of technology transfer, 2007-08, Vol.32 (4), p.367-395</ispartof><rights>Springer Science+Business Media, LLC 2007</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-e6a251ba9b7b70fa25bcae7fbc00144be2cb2cce5997912c1236ee1769187c6c3</citedby><cites>FETCH-LOGICAL-c403t-e6a251ba9b7b70fa25bcae7fbc00144be2cb2cce5997912c1236ee1769187c6c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Wong, Poh-Kam</creatorcontrib><title>Commercializing biomedical science in a rapidly changing “triple-helix” nexus: The experience of the National University of Singapore</title><title>The Journal of technology transfer</title><description>Since the late 1990s, the Singapore government had embarked on a significant push to develop the city-state into a major life-science R&D and industrial cluster in Asia. Although a major focus of this new thrust involves attracting leading life science companies overseas to establish operations in Singapore and developing new public life science research institutions to attract overseas life science research talents (Finegold, Wong, and Cheah (2004)), the local universities are expected to play an important role as well. In particular, the National University of Singapore (NUS), the leading university in Singapore, has also started to pursue major strategic change to become more “entrepreneurial”, and identified life science as a major focus for technology commercialization as well. Adapting the “Triple-Helix” framework of Etzkowitz, Webster, Gebhardt, & Terra (2000), this paper examines the significant changes in the university-government-industry “Triple-Helix” nexus for life science in Singapore, and their consequent impact on life science commercialization at NUS. Implications for universities in other late-comer countries seeking to catch up in the global biotech race are discussed.</description><subject>Biomedical research</subject><subject>Biotechnology</subject><subject>Biotechnology industry</subject><subject>Clusters</subject><subject>Colleges & universities</subject><subject>Commercialization</subject><subject>Competition</subject><subject>Economic development</subject><subject>Economic growth</subject><subject>Effects</subject><subject>Entrepreneurs</subject><subject>Funding</subject><subject>Globalization</subject><subject>Governments</subject><subject>Health care policy</subject><subject>Innovations</subject><subject>issues and policy</subject><subject>Life sciences</subject><subject>Manufacturing</subject><subject>Overseas</subject><subject>Pharmaceutical industry</subject><subject>Public policy</subject><subject>Race</subject><subject>Regional differences</subject><subject>research and development</subject><subject>Research centers</subject><subject>Studies</subject><subject>Technology transfer</subject><subject>Thrust</subject><subject>University research</subject><subject>Venture capital</subject><issn>0892-9912</issn><issn>0892-9912</issn><issn>1573-7047</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkb1OwzAQxyMEEp8PwITFxBI4O00cs6GKLwnBUDpbjrm0Rkkc7BS1TF15B3i5PgmOwoCYfL773U86_aPomMI5BeAXnoLIaAyQxQIYxLAV7UEuWCwEZdt_6t1o3_tXABgB43vR59jWNTptVGU-TDMjhbE1vhitKuK1wUYjMQ1RxKnWvFQroueqmfXgZv3VOdNWGM-xMsvN-ps0uFz4S_I8R4LLFt2wbkvShc6j6oxtgnbamHd03nSrfjQJLtVah4fRTqkqj0e_70E0vbl-Ht_FD0-39-Orh1iPIOlizBRLaaFEwQsOZfgUWiEvCw1AR6MCmS6Y1pgKwcO5mrIkQ6Q8EzTnOtPJQXQ2eFtn3xboO1kbr7GqVIN24SWFnNE8Aw4BPf2HvtqFCzd4ySDJ0kTwNEB0gLSz3jssZetMrdwqmGSfjRyykSEb2Wcje_HJsFMqK9XMGS-nEwY0CTjPRcqSHxkUjug</recordid><startdate>20070801</startdate><enddate>20070801</enddate><creator>Wong, Poh-Kam</creator><general>New York : Kluwer Academic Publishers-Plenum Publishers</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>7TA</scope><scope>7TB</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X5</scope><scope>7XB</scope><scope>87Z</scope><scope>88I</scope><scope>8A3</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FRNLG</scope><scope>F~G</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>JG9</scope><scope>K60</scope><scope>K6~</scope><scope>L.-</scope><scope>L.0</scope><scope>M0C</scope><scope>M2P</scope><scope>P5Z</scope><scope>P62</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>20070801</creationdate><title>Commercializing biomedical science in a rapidly changing “triple-helix” nexus: The experience of the National University of Singapore</title><author>Wong, Poh-Kam</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-e6a251ba9b7b70fa25bcae7fbc00144be2cb2cce5997912c1236ee1769187c6c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Biomedical research</topic><topic>Biotechnology</topic><topic>Biotechnology industry</topic><topic>Clusters</topic><topic>Colleges & universities</topic><topic>Commercialization</topic><topic>Competition</topic><topic>Economic development</topic><topic>Economic growth</topic><topic>Effects</topic><topic>Entrepreneurs</topic><topic>Funding</topic><topic>Globalization</topic><topic>Governments</topic><topic>Health care policy</topic><topic>Innovations</topic><topic>issues and policy</topic><topic>Life sciences</topic><topic>Manufacturing</topic><topic>Overseas</topic><topic>Pharmaceutical industry</topic><topic>Public policy</topic><topic>Race</topic><topic>Regional differences</topic><topic>research and development</topic><topic>Research centers</topic><topic>Studies</topic><topic>Technology transfer</topic><topic>Thrust</topic><topic>University research</topic><topic>Venture capital</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wong, Poh-Kam</creatorcontrib><collection>AGRIS</collection><collection>CrossRef</collection><collection>Global News & ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Materials Business File</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Entrepreneurship Database</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Entrepreneurship Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Business Premium Collection (Alumni)</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Materials Research Database</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ABI/INFORM Global</collection><collection>Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>One Business (ProQuest)</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>The Journal of technology transfer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wong, Poh-Kam</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Commercializing biomedical science in a rapidly changing “triple-helix” nexus: The experience of the National University of Singapore</atitle><jtitle>The Journal of technology transfer</jtitle><date>2007-08-01</date><risdate>2007</risdate><volume>32</volume><issue>4</issue><spage>367</spage><epage>395</epage><pages>367-395</pages><issn>0892-9912</issn><eissn>0892-9912</eissn><eissn>1573-7047</eissn><abstract>Since the late 1990s, the Singapore government had embarked on a significant push to develop the city-state into a major life-science R&D and industrial cluster in Asia. Although a major focus of this new thrust involves attracting leading life science companies overseas to establish operations in Singapore and developing new public life science research institutions to attract overseas life science research talents (Finegold, Wong, and Cheah (2004)), the local universities are expected to play an important role as well. In particular, the National University of Singapore (NUS), the leading university in Singapore, has also started to pursue major strategic change to become more “entrepreneurial”, and identified life science as a major focus for technology commercialization as well. Adapting the “Triple-Helix” framework of Etzkowitz, Webster, Gebhardt, & Terra (2000), this paper examines the significant changes in the university-government-industry “Triple-Helix” nexus for life science in Singapore, and their consequent impact on life science commercialization at NUS. Implications for universities in other late-comer countries seeking to catch up in the global biotech race are discussed.</abstract><cop>Indianapolis</cop><pub>New York : Kluwer Academic Publishers-Plenum Publishers</pub><doi>10.1007/s10961-006-9020-0</doi><tpages>29</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0892-9912 |
| ispartof | The Journal of technology transfer, 2007-08, Vol.32 (4), p.367-395 |
| issn | 0892-9912 0892-9912 1573-7047 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1082186070 |
| source | SpringerLink Journals - AutoHoldings |
| subjects | Biomedical research Biotechnology Biotechnology industry Clusters Colleges & universities Commercialization Competition Economic development Economic growth Effects Entrepreneurs Funding Globalization Governments Health care policy Innovations issues and policy Life sciences Manufacturing Overseas Pharmaceutical industry Public policy Race Regional differences research and development Research centers Studies Technology transfer Thrust University research Venture capital |
| title | Commercializing biomedical science in a rapidly changing “triple-helix” nexus: The experience of the National University of Singapore |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T23%3A51%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Commercializing%20biomedical%20science%20in%20a%20rapidly%20changing%20%E2%80%9Ctriple-helix%E2%80%9D%20nexus:%20The%20experience%20of%20the%20National%20University%20of%20Singapore&rft.jtitle=The%20Journal%20of%20technology%20transfer&rft.au=Wong,%20Poh-Kam&rft.date=2007-08-01&rft.volume=32&rft.issue=4&rft.spage=367&rft.epage=395&rft.pages=367-395&rft.issn=0892-9912&rft.eissn=0892-9912&rft_id=info:doi/10.1007/s10961-006-9020-0&rft_dat=%3Cproquest_cross%3E1279164641%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=203653975&rft_id=info:pmid/&rfr_iscdi=true |